Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (324)

« Back to Publications

Active immunisation targeting nerve growth factor attenuates chronic pain behaviour in murine osteoarthritis.

von Loga IS. et al, (2019), Ann Rheum Dis, 78, 672 - 675

Active vaccination against interleukin-5 as long-term treatment for insect-bite hypersensitivity in horses.

Fettelschoss-Gabriel A. et al, (2019), Allergy, 74, 572 - 582

The 5th virus-like particle and nano-particle vaccines (VLPNPV) conference.

Engeroff P. and Bachmann MF., (2019), Expert Rev Vaccines, 18, 1 - 3

A vaccine against Alzheimer`s disease: anything left but faith?

Bachmann MF. et al, (2019), Expert Opin Biol Ther, 19, 73 - 78

Induction of Human T-cell and Cytokine Responses Following Vaccination with a Novel Influenza Vaccine.

Skibinski DAG. et al, (2018), Sci Rep, 8

An unexpected protective role of low-affinity allergen-specific IgG through the inhibitory receptor FcγRIIb.

Zha L. et al, (2018), J Allergy Clin Immunol, 142, 1529 - 1536.e6

Treating insect-bite hypersensitivity in horses with active vaccination against IL-5.

Fettelschoss-Gabriel A. et al, (2018), J Allergy Clin Immunol, 142, 1194 - 1205.e3

Biosensor-based selective detection of Zika virus specific antibodies in infected individuals.

Cabral-Miranda G. et al, (2018), Biosens Bioelectron, 113, 101 - 107

A novel recycling mechanism of native IgE-antigen complexes in human B cells facilitates transfer of antigen to dendritic cells for antigen presentation.

Engeroff P. et al, (2018), J Allergy Clin Immunol, 142, 557 - 568.e6

HealVax.

Foerster J. and Bachmann M., (2018), Hum Vaccin Immunother, 14, 1546 - 1547

Interaction of Viral Capsid-Derived Virus-Like Particles (VLPs) with the Innate Immune System.

Mohsen MO. et al, (2018), Vaccines (Basel), 6

Vaccination against IL-31 for the treatment of atopic dermatitis in dogs.

Bachmann MF. et al, (2018), J Allergy Clin Immunol, 142, 279 - 281.e1

Allergens displayed on virus-like particles are highly immunogenic but fail to activate human mast cells.

Engeroff P. et al, (2018), Allergy, 73, 341 - 349

Virus-like particles (VLP) in prophylaxis and immunotherapy of allergic diseases.

Klimek L. et al, (2018), Allergo J Int, 27, 245 - 255

The Prospects of an Active Vaccine Against Asthma Targeting IL-5.

Bachmann MF. et al, (2018), Front Microbiol, 9

Load More

1
2
3
4
5
6
7
...
»